Investor Relations

Company Profile

Amphastar is a bio-pharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling technically-challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells insulin API products. Most of the Company’s finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers.

Company News

02Sep 2021

Amphastar Pharmaceuticals to Present at the Wells Fargo 2021 Virtual Healthcare Conference

More
09Aug 2021

Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended June 30, 2021

More

Financial Calendar

09Aug 2021

Amphastar Second Quarter Earnings Call

Add to Calendar
06May 2021

Amphastar First Quarter Earnings Call

Add to Calendar
15Mar 2021

Amphastar Fourth Quarter Earnings Call

Add to Calendar

Email Alert

Subscribe to our newsletter

Spam protection: Please accept and solve the Captcha if prompted.